NCT05111743View on ClinicalTrials.gov

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (Komodo Health)

CompletedOBSERVATIONAL
Enrollment

9,261

Participants

Timeline

Start Date

June 17, 2020

Primary Completion Date

December 18, 2020

Study Completion Date

December 18, 2020

Conditions
Age-related Macular Degeneration (AMD)
Interventions
DRUG

Brolucizumab

Participants received brolucizumab injection during the index period

Trial Locations (1)

79361080

Novartis Investigative Site, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY